# OnCo record daromun (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/daromun/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "daromun" ;
  schema:name "Daromun"@en ;
  schema:alternateName "L19IL2 + L19TNF"@en, "Onfekafusp alfa and bifikafusp alfa"@en, "Darleukin + Fibromun"@en ;
  schema:description "Daromun is a pair of antibody-linked immune messengers injected straight into melanoma deposits before surgery. In a phase 3 trial it lowered the chance of the melanoma coming back after the operation compared with surgery alone."@en ;
  schema:url <https://onco.cc/drugs/daromun/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:status "phase-3" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Intralesional immunocytokine combination" ;
  onco:related <https://onco.cc/drugs/talimogene-laherparepvec/> ;
  onco:cancers <https://onco.cc/cancers/stage-iii-melanoma/> ;
  onco:technologies <https://onco.cc/technologies/immunocytokines/> ;
  onco:companies <https://onco.cc/companies/philogen-s-p-a/> .